Therapeutic Asset Ratings

105 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
HAFNIUM OXIDE Metastatic Malignant Neoplasm in the Lung	M.D. Anderson Cancer Center	P1/2	CCC (48)
lutetium (<sup>177</sup>Lu) zadavotide guraxetan Metastatic Clear Cell Renal Cell Carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CCC (48)
Pasifolate Exatecan Endometrial Adenocarcinoma	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Endometrial Carcinosarcoma	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Endometrial Clear Cell Adenocarcinoma	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Endometrial Diseases	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Endometrioid Adenocarcinoma	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Endometrioid Tumor	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Ovarian Adenocarcinoma	Elucida Oncology	P1/2	CCC (48)
Pasifolate Exatecan Ovary Disease	Elucida Oncology	P1/2	CCC (48)
POLY((N-(2-HYDROXYPROPYL)METHACRYLAMIDE)-CO-(METHACRYLOYL-GLY-PHE-LEU-GLY AMIDE WITH O-((TRANS-4-AMINOCYCLOHEXYL)CARBAMOYL)FUMAGILLOL)) (~0.91:0.09 X) HR+/HER2-negative Breast Cancer	SynDevRx, Inc.	P1/2	CCC (48)
Pasifolate Exatecan Ovarian Serous Adenocarcinoma	Elucida Oncology	P1/2	CC (47)
HAFNIUM OXIDE Advanced Malignant Solid Neoplasm	M.D. Anderson Cancer Center	P1/2	CC (45)
HAFNIUM OXIDE Metastatic Malignant Neoplasm in the Liver	M.D. Anderson Cancer Center	P1/2	CC (45)
lutetium (<sup>177</sup>Lu) zadavotide guraxetan Metastatic Renal Cell Carcinoma	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P1/2	CC (45)
Pasifolate Exatecan Endometrial Neoplasms	Elucida Oncology	P1/2	CC (45)
Pasifolate Exatecan Ovarian Carcinoma	Elucida Oncology	P1/2	CC (45)
Pasifolate Exatecan Peritoneal Cancer	Elucida Oncology	P1/2	CC (45)
Cholestyramine Advanced Pancreatic Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
Cholestyramine Stage III Pancreatic Cancer AJCC v8	City of Hope Medical Center	P1	CC (43)
Cholestyramine Unresectable Pancreatic Ductal Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
HAFNIUM OXIDE Borderline Resectable Pancreatic Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Locally Advanced Pancreatic Ductal Adenocarcinoma	M.D. Anderson Cancer Center	P1	CC (43)
HAFNIUM OXIDE Metastasis From Malignant Melanoma of Skin (Disorder)	Nanobiotix	P1	CC (43)
HAFNIUM OXIDE Metastasis From Malignant Tumor of Bladder (Disorder)	Nanobiotix	P1	CC (43)

Showing 26 to 50 of 105 assets

PreviousPage 2 of 5Next